Vanguard Group Inc Harvard Bioscience Inc Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Vanguard Group Inc holds 2,152,147 shares of HBIO stock, worth $6.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,152,147

Previous 2,102,571 2.36%

Holding current value

$6.26 Million

Previous $11.2 Million 18.87%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$4.02 - $5.39 $199,295 - $267,214	49,576 Added 2.36%	2,152,147 $9.13 Million
Q4 2023 Feb 14, 2024	BUY	$4.0 - $5.49 $152,676 - $209,547	38,169 Added 1.85%	2,102,571 $11.2 Million
Q3 2023 Nov 14, 2023	BUY	$4.0 - $5.82 $409,540 - $595,880	102,385 Added 5.22%	2,064,402 $8.88 Million
Q2 2023 Aug 14, 2023	BUY	$4.19 - $6.16 $913,507 - $1.34 Million	218,021 Added 12.5%	1,962,017 $10.8 Million
Q1 2023 May 15, 2023	BUY	$2.45 - $4.22 $1.19 Million - $2.05 Million	486,198 Added 38.65%	1,743,996 $7.32 Million

Q4 2022 Feb 10, 2023	SELL	$2.12 - $2.86 $594,628 - $802,187	-280,485 Reduced 18.23%	1,257,798 $3.48 Million
Q2 2022 Aug 12, 2022	SELL	$3.28 - $6.42 $1.27 Million - $2.48 Million	-386,234 Reduced 20.07%	1,538,283 $5.54 Million
Q1 2022 May 13, 2022	BUY	$5.16 - $7.14 $1.13 Million - $1.56 Million	218,832 Added 12.83%	1,924,517 $12 Million
Q4 2021 Feb 14, 2022	SELL	$6.37 - $8.18 $611,647 - $785,443	-96,020 Reduced 5.33%	1,705,685 $12 Million
Q3 2021 Nov 12, 2021	SELL	$6.98 - $8.47 $866,657 - $1.05 Million	-124,163 Reduced 6.45%	1,801,705 $12.6 Million
Q2 2021 Aug 13, 2021	BUY	$5.44 - $8.4 $10.5 Million - $16.2 Million	1,925,868 New	1,925,868 $16 Million

Others Institutions Holding HBIO

# of Institutions

Shares Held

32.8M

Call Options Held

Put Options Held

2.2K

View Full List

About HARVARD BIOSCIENCE INC

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $121M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

More about HBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Harvard Bioscience Inc Transaction History